View Author
patient plasma concentration children indinavir study ritonavir sample assay lopinavir group therapy antiretroviral inhibitor level pharmacokinetic analysis blood infection treatment netherland lamivudine atazanavir response efavirenz protease leukocyturia virus hiv protease inhibitors plasma concentrations raltegravir department effect baseline dose reduction value hiv-infected patients hiv-infected month antiretroviral therapy university count nvp plasma concentrations table women adult intracellular disease reduction pregnancy incidence nevirapine virological haart result immunodeficiency maldi-qqq-m signi ficantly atovaquone signi nijmegen hiv -1-infected children adherence radboud university nijmegen creatinine spectrometry center intracellular concentrations range ratio hospital discontinuation article increase hiv infection side effects /ritonavir rotterdam quadrupole serum
10 Most Recent Publications
|
Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots
(Article)
Meesters, R.J.W. Kampen, J.J.A. van Reedijk, M.L. Scheuer, R.D. Dekker, L.J.M. Burger, D.M. Hartwig, N.G. Osterhaus, A.D.M.E. Luider, T.M. Gruters, R.A. |
2010-09-01
|
|
Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: A clinical application of MALDI mass spectrometry
(Article)
Kampen, J.J.A. van Reedijk, M.L. Gruters, R.A. Burgers, P.C. Dekker, L.J.M. Hartwig, N.G. Ende, I.E. van der Groot, R. de Osterhaus, A.D.M.E. Burger, D.M. Luider, T.M. |
2010-08-13
|
|
Correspondence : Switching from Efavirenz to Nevirapine
(Article)
Gelinck, L.B.S. Burger, D.M. |
2010-08-01
|
|
Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir
(Article)
Luin, M. van Ende, M.E. van der Kuks, P.F. Burger, D.M. Richter, C. Visser, M. Faraj, D. Ven, A. van der Gelinck, L.B.S. Kroon, F.P. Wit, F.W. Schaik, R.H.N. van |
2010-05-01
|
|
Pharmacokinetics of double-dose raltegravir in two patients with hiv infection and tuberculosis
(Article)
Burger, D.M. Magis-Escurra, C. Berk, G.E.L. van den Gelinck, L.B.S. |
2010-01-01
|
|
Efavirenz dose reduction is safe in patients with high plasma concentrations and may prevent efavirenz discontinuations
(Article)
Luin, M. van Gras, L. Richter, C. Ende, M.E. van der Prins, J.M. Wolf, F.D. Burger, D.M. Wit, F.W. |
2009-10-01
|
|
Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin
(Article)
Luin, M. van Brouwer, A.M. Ven, A.D. van Lange, W. de Schaik, R.H.N. van Burger, D.M. |
2009-03-27
|
|
Steady-state nevirapine plasma concentrations are influenced by pregnancy
(Article)
Nellen, J.F.J.B. Damming, M. Godfried, M.H. Boer, K. Ende, M.E. van der Burger, D.M. Wolf, F. de Wit, F.W. Prins, J.M. |
2008-04-01
|
|
Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice
(Article)
Cleijsen, R.M.M. Ende, M.E. van der Kroon, F.P. Lunel, verduyn F. Koopmans, P.P. Gras, L. Wolf, F. de Burger, D.M. |
2007-10-01
|
|
Indinavir/low-dose ritonavir containing HAART in HIV-1 infected children has potent antiretroviral activity, but is associated with side effects and frequent discontinuation of treatment
(Article)
Fraaij, P.L.A. Verweel, G. Rossum, A.M.C. van Hartwig, N.G. Burger, D.M. Groot, R. de |
2007-06-01
|